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Abstract
Background: The intracellular protozoan parasite Theileria parva transforms bovine lymphocytes inducing uncontrolled
proliferation. Proteins released from the parasite are assumed to contribute to phenotypic changes of the host cell and
parasite persistence. With 85 members, genes encoding subtelomeric variable secreted proteins (SVSPs) form the largest
gene family in T. parva. The majority of SVSPs contain predicted signal peptides, suggesting secretion into the host cell
cytoplasm.
Methodology/Principal Findings: We analysed SVSP expression in T. parva-transformed cell lines established in vitro by
infection of T or B lymphocytes with cloned T. parva parasites. Microarray and quantitative real-time PCR analysis revealed
mRNA expression for a wide range of SVSP genes. The pattern of mRNA expression was largely defined by the parasite
genotype and not by host background or cell type, and found to be relatively stable in vitro over a period of two months.
Interestingly, immunofluorescence analysis carried out on cell lines established from a cloned parasite showed that
expression of a single SVSP encoded by TP03_0882 is limited to only a small percentage of parasites. Epitope-tagged
TP03_0882 expressed in mammalian cells was found to translocate into the nucleus, a process that could be attributed to
two different nuclear localisation signals.
Conclusions: Our analysis reveals a complex pattern of Theileria SVSP mRNA expression, which depends on the parasite
genotype. Whereas in cell lines established from a cloned parasite transcripts can be found corresponding to a wide range
of SVSP genes, only a minority of parasites appear to express a particular SVSP protein. The fact that a number of SVSPs
contain functional nuclear localisation signals suggests that proteins released from the parasite could contribute to
phenotypic changes of the host cell. This initial characterisation will facilitate future studies on the regulation of SVSP gene
expression and the potential biological role of these enigmatic proteins.
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Introduction
The subtelomeres of many pathogenic microorganisms contain
gene families involved in host-pathogen interactions such as
adherence, invasion or escape from immunity (reviewed in [1]).
Well-documented examples include the var genes in Plasmodium
falciparum [2], the vsg genes in Trypanosoma brucei [3] and the EPA
genes in the pathogenic fungus Candida glabrata [4]. The location in
telomere-associated regions allows special mechanisms to regulate
gene expression. In addition telomere clustering at the nuclear
periphery can promote ectopic recombination in telomere-
proximal gene families leading to antigenic variation [1].
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Heterochromatin, the condensed and transcriptionally inactive
form of chromatin, is constitutively present at telomeres and the
resulting transcriptional silencing has been described as ‘‘telomere
position effect’’ [5]. Post-translational modifications of histones can
regulate the extent of condensation and heterochromatin-mediat-
ed regulation is one mechanism used by many pathogens to
control differential expression of members of subtelomeric gene
families [6]. In P. falciparum, for instance, the exclusive and
alternating expression of one single var gene at a time is under
heterochromatin-mediated control [2].
The protozoan parasites Theileria parva and Theileria annulata, like
Plasmodium spp., belong to the phylum Apicomplexa. Both Theileria
parasites are transmitted by ixodid ticks, causing fatal cattle diseases
in large parts of Africa and Asia, respectively. After invasion of
bovine lymphocytes, Theileria sporozoites rapidly eliminate the
enclosing host cell membrane and over the next two to three days,
the parasite-now free in the cytoplasm-differentiates into a
multinucleated schizont [7]. T. parva and T. annulata schizonts
have the unique ability among eukaryotic microorganisms to
convert the host cells they infect into a transformed state. This is
accompanied by uncontrolled proliferation and resistance to
apoptosis. Theileria-transformed cells also acquire the capacity to
metastasise (reviewed in [8,9]).
While the host signalling pathways mediating these phenotypic
alterations have been studied in considerable detail, the parasite
factors involved are largely unknown (reviewed in [10,11,12,13].
In the cytoplasm, the parasite is perfectly positioned to interfere
with host cell pathways that regulate proliferation and survival.
This can involve events that occur at the parasite surface, as shown
for the NF-kB activation pathway [14], or potentially also through
secreted parasite proteins [15,16,17].
Secreted proteins are of particular interest as they theoretically
have the highest potential for processing by the proteasome and
presentation of peptides in association with bovine host MHC
Class I molecules. The elimination of T. parva-infected lympho-
cytes by MHC class I-restricted cytotoxic T cell responses is a
proven effector mechanism for protective immunity in cattle
[18,19]. Therefore such proteins could also function as vaccine
antigens and there is preliminary evidence to support this [20,21].
While screening a T. parva library using the yeast-2-hybrid
system, we made the chance discovery of several members of a
novel gene family encoding glutamine (Q)- and proline (P)-rich
proteins, most of which contained putative signal peptides for
secretion. These proteins were distinct from PIM (polymorphic
immunodominant molecule), also called QP-protein [22,23].
Upon completion of the T. parva and T. annulata genome sequences
[24,25] it became clear that the identified genes were part of a
large and unique family located in a telomere-associated region of
all four Theileria chromosomes. The gene family was originally
designated subtelomeric variable secreted protein (SVSP) gene
family. We suggest to designate the family ‘subtelomere-encoded
variable secreted proteins’ (SVSP) because the genes (rather than
the proteins) are clearly subtelomeric and there is no evidence that
the (SVSP) proteins themselves localise to subtelomeric regions.
With 85 members in T. parva and 48 members in T. annulata, it is
the largest family observed in these organisms. Between 2 and 26
genes within this family are located at each of the eight
chromosome ends, arranged in tandem arrays with very short
intergenic regions of about 200 to 300 base pairs and aligned in
centromeric-telomeric direction [24,25]. The organisation of the
SVSP genes is schematically presented in Fig. S1. An analysis using
SignalP software [26] predicts that many SVSPs have a signal
peptide for access to the parasite secretory pathway (Table S2)
[25].
The amino acid sequence of a SVSP (TP03_0882) containing the
characteristic features of this family is presented in Figure 1A. The
general structure of SVSPs consists of a short conserved N-terminal
region, in most cases containing a putative signal peptide for
secretion, followed by a QP-rich region which is predicted to be
highly unstructured (Fig. 1B) [27]. The conserved C-terminus has
no significant identity to known proteins and nearly all SVSP
molecules contain Theileria-specific, highly divergent domains
termed ‘frequently associated in Theileria’ (FAINT). The function
of these domains that contain approximately 70 amino acid
residues is currently unknown [25].
Information obtained from analysis of the T. parva transcrip-
tome by massively parallel signature sequencing (MPSS) technol-
ogy combined with the fact that we isolated several SVSP clones
from a cDNA library indicates that many SVSP genes are
transcribed in the schizont stage ([25,28] and data not shown).
The analysis by MPSS of SVSP transcripts in a cell line
transformed by T. parva (Muguga) [29] suggested a mosaic-like
expression pattern (see Fig. S1 for an overview of SVSP gene
organisation and expression as reported by Bishop et al. [28]).
Figure 1. Schematic presentation of TP08_0882, a typical SVSP. A. Schematic view and amino acid sequence of TP03_0882. TP03_0882 is 607
amino acids long. The polypeptide has a putative signal peptide (SP) for secretion (purple) with a cleavage site after residue 21 (predicted by the
SignalP3.0 web server). A large N-terminal region containing abundant Q and P residues (red) is followed by C-terminal region containing two nuclear
localisation signals (NLS 1 and 2, blue) and two FAINT domains from aa 422 to 481 and aa 520 to 579 (green). B. Analysis of the TP03_0882 protein
using the FoldIndex software. The N-terminal region of the protein is intrinsically unfolded, while the conserve C-terminal region is predicted to
fold.
doi:10.1371/journal.pone.0004839.g001
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Allocating transcripts from a single infected cell line to individual
genes, those expressed at low levels (4-99 transcripts per million)
were found to alternate with genes expressed at medium levels
(100-999 transcripts per million), and transcribed genes were
interspersed with SVSP genes for which no transcripts were
detectable.
The present paper provides an initial characterisation of this
unusual T. parva gene family. We analysed the expression of SVSP
genes in a set of phenotypically different cell lines, established by
infection with cloned T. parva parasites, to investigate whether the
pattern of expression is conserved or changes depending on
parasite genotype, or host cell type and background. Using anti-
SVSP antibodies, we present the first evidence for SVSP protein
expression. By transfecting mammalian cells with different SVSP
constructs, we show that the nuclear localisation signals (NLS)
found in several SVSPs are functional and can target SVSPs to
different nuclear compartments.
Results
Expression patterns of SVSP genes in different T. parva-
infected cloned cell lines
In order to investigate whether SVSP genes are differentially
expressed depending on the host cell type the parasite resides in,
we compared transcript levels in a CD4+ T cell line (211T-A3)
and a B cell line (211B-A3) originating from the animal 211 that
was infected with the T. parva (Marikebuni) clone A3 [30]. A
microarray was used that contained 70-mer probes corresponding
to 78 of the 85 SVSP genes. Seven SVSP genes were not
represented on the microarray because appropriate probes could
not be designed due to the presence of low complexity regions,
lack of uniqueness and/or unsuitable GC content falling outside
the required range (Kang’a et al., in preparation). Of the 78 SVSPs
analyzed, transcripts of 56 genes were detected (Table S1 and Fig.
S1). At the different subtelomeres, the 22 genes with no detectable
transcripts were interspersed between transcribed SVSPs. For a
block of 9 genes on the reverse strand of chromosome 3, evidence
for transcription was absent. However, this region spanning loci
TP03_0871 to TP03_0880 also includes 4 genes that were not
represented on the microarrays. Two of these 4 genes share 100%
identity with another gene (TP03_0871 is identical to TP03_0884;
TP03_0879 is identical to TP03_0874) and TP03_0873 is
identical to TP03_0878 except for the first 27 bp. As no transcripts
were detected for TP03_0874 and TP03_0878 and as probes were
designed corresponding to 39 regions of the genes it can be
concluded that also TP03_0879 and TP03_0873 are not
expressed. Because TP03_0871 is identical to TP03_0884, the
transcript detected by microarray analysis suggests that one or
both genes are expressed. SVSP genes for which no transcripts
could be detected were located at all subtelomeres except the
reverse strands of chromosomes 1 and 4. Genes with log2 ratios
higher than 0.9 (which corresponds to an approximately two-fold
difference) were considered as differentially expressed. When the
T- and B-cell lines (211T-A3 and 211B-A3) transformed by T.
parva (Marikebuni) A3 were compared, for most of the genes no
significant difference in transcript level could be detected. Only
two genes, TP02_0954 and TP03_0890, showed slightly elevated
transcript levels in the T cell line (log2 ratios of 0.9 and 1.4,
respectively; Table S1).
Next, SVSP expression in the two T. parva (Marikebuni) A3-
infected cell lines was compared to that for a third cell line, 951T-
F44, consisting of CD4+ T cells (derived from animal 951)
transformed by the T. parva (Marikebuni) clone F44 [30,31].
Compared to the cells transformed with the A3 clone, transcript
levels for the majority of SVSP genes were largely conserved in the
cell line 951T-F44. However, there were eight genes for which
differential expression above the threshold of a log2 ratio of 0.9
was detected (Table S1, Fig. S1). These initial findings indicated
that multiple SVSP genes are transcribed simultaneously in cell
lines obtained by transformation of T and B cells with cloned T.
parva (Marikebuni) parasites. A small percentage of SVSP genes,
however, also appear to be differentially expressed.
In order to consolidate the observations obtained using
microarrays, we performed quantitative real-time PCR (qRT-
PCR) and monitored the expression of 11 SVSP genes using the
same total RNA that had been prepared for the microarray
analysis. In addition to the genes TP02_0954 and TP03_0890 we
analyzed two genes for which no transcripts were detected in
microarray experiments (TP02_0953 and TP04_0018), one gene
for which no differential expression was observed in all three cell
lines (TP03_0882) and the genes TP01_0004, TP03_0869,
TP03_0883, TP03_0887, TP04_0007 and TP04_0921, which,
according to microarray analysis, were differentially expressed in
the cell line 951T-F44. Transcript levels of these eleven genes were
compared in the cell lines 211T-A3 and 211B-A3. For the eleven
SVSPs analyzed, no significant difference in transcript levels could
be observed when CD4+ T cells or B cells transformed by the T.
parva (Marikebuni) A3 clone were compared (Fig. 2A). A schematic
overview of the position of these genes at the telomeres of
chromosomes 1 to 4 is shown in Fig. S1. The small differences in
transcript levels of the genes TP02_0954 and TP03_0890 observed
by microarray analysis could not be confirmed. In relation to the
cell line 951T-F44, the overall SVSP expression pattern in 211T-
A3 and 211B-A3 was highly similar (Fig. 2B). For single SVSP
genes, however, transcript levels observed in the cell line 951T-
F44 differed clearly from that observed for the other two cell lines
(Fig. 2B), with some genes showing higher and other genes lower
quantities of steady state mRNA. As the cell line 951T-F44 is
derived from a different animal and harbours a different parasite
clone, it was not clear whether the altered expression pattern could
be attributed to the host background, or parasite genotype. To
address this question, relative expression levels of five selected
SVSP genes were assessed in seven different T. parva-infected cell
lines. These included T. parva (Marikebuni) A3 in B cells of two
different animals (211B-A3 and 951B-A3), two different T. parva
(Marikebuni) clones in cd T cells of the same animal (951T-I8 and
951T-F31), and three CD4+ T cell lines, each harbouring one of
two different T. parva (Marikebuni) clones or a T. parva (Muguga)
clone (951T-F44, 951T-F53 and 951T-S80.9) (Table 2). For the
five genes analyzed, no difference in transcript levels (with more
than two-fold difference) was observed when T. parva (Marikebuni)
A3 parasitizing B cells from two different animals was compared
(Fig. 3, first two bars in all five panels). By contrast, pronounced
differences were detected in cell lines infected with different
parasite clones. For instance, in infected CD4+ T cell lines of
animal 951, transcript levels of TP03_0869 and TP04_0921 are
much lower in the clone T. parva (Marikebuni) F44 than in T. parva
(Marikebuni) F53 (to a maximum of an approximately 64-fold
difference), while transcript levels of these two genes are
comparable in the T. parva (Marikebuni) clone F53 and the T.
parva (Muguga) clone S80.9 (Fig. 3, last two bars). On the other
hand, TP03_0887 transcript levels are five times higher in T. parva
(Marikebuni) F44 than in T. parva (Marikebuni) F53. T. parva
(Marikebuni) F31 in the cd T cell line of animal 951 has an
approximately five-fold higher level of TP03_0883 transcripts than
T. parva (Marikebuni) I8 on the same host cell background (Fig. 3).
As TP03_0877 belongs to a small region for which specific
probes for microarray analysis were not available, transcript levels
Theileria SVSP Expression
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were also analysed by qRT-PCR in the cell lines 951B-A3 and
951T-F44. With a log2 ratio of 1, the mRNA expression level was
found to be slightly elevated in 951T-F44 compared to 951B-A3
(Fig. S1). This data is not included in Fig. 2B as different RNA
preparations were used than for the microarray analysis.
Sub-telomeric regions are often highly polymorphic [32] and this
has been demonstrated for T. parva ORFs located in telomere-
associated DNA [33]. In order to exclude the possibility that the
observed differences in transcript levels are caused by suboptimal
hybridisation of the microarray probes or the PCR primers due to
polymorphisms in different parasite genotypes, we sequenced
selected gene fragments from different cell lines. Fragments of
approximately 1000 bp encompassing the target sites for microarray
probes and qRT-PCR primers in the genes TP03_0869, TP03_0883
and TP04_0921 of the cell lines 951-A3, 951T-F44, 951T-F31, 951-
I8 and 951T-S80.9 were sequenced. Apart from one single
nucleotide not affecting the hybridization region, sequences were
identical in all cell lines (data not shown).
To test whether the pattern of SVSP expression is stable,
transcript levels of TP03_0869, TP04_0018 and TP04_0921 in the
F44, F53 and S80-9 genetic parasite background were monitored
weekly by qRT-PCR analysis for a period of 8 weeks in several cell
lines. Results indicated that the expression pattern of the SVSPs
tested is largely stable and, at least in vitro, does not fluctuate
significantly over the time period tested (data not shown).
In conclusion, while many SVSP genes appear to be expressed in
different T. parva-transformed cell lines, the transcript levels of
single SVSP genes can vary considerably depending on the parasite
genotype. However, we found no evidence for a possible influence
of the host cell background on differential SVSP mRNA expression
between parasite clones with the same genotype.
Detection of T. parva SVSP protein expression
To investigate whether SVSP expression can also be demon-
strated at the protein level, we generated rat polyclonal antibodies
directed against the C-terminal conserved domain of SVSP
TP03_0882. Since the recombinant protein used for immunisation
contained a V5/His epitope tag for detection and purification, the
serum was also expected to contain antibodies against V5/His. To
confirm that the antiserum contains antibodies against the SVSP
backbone, the epitope tag was removed from the recombinant
protein using AcTEV protease and the resulting protein fragments
analysed by immunoblot. A lower molecular weight cleavage
product lacking the V5 epitope was readily detectable confirming
that antibodies specifically recognizing recombinant SVSP had
been generated (Fig. 4A). This was also confirmed by the fact that
antibodies reacted with untagged recombinant TP03_0882 protein
or with recombinant TY-tagged TP03_0882 protein, but not with
other TY-tagged proteins (Fig. 4B). TP03_0882 SVSP could not be
detected in extracts prepared from T. parva (Muguga)-infected
TpMD409 CD8+ T cells (Fig. 4B, line 6), most likely because only
a minority of the parasitised cells express this protein (see below).
Using the anti-SVSP immune serum, we performed immuno-
fluorescence analysis on BoMac cells expressing recombinant TY-
tagged TP03_0882 and also on T. parva-infected bovine leukocytes
(TpMD409 CD8+ T cells). In BoMac cells, recombinant
TP03_0882 was readily detected, localising predominantly to the
nucleus of the transfected cell. Fig. 4C shows one example of a
BoMac-transfected cell in which the nucleus is strongly stained,
except for the nucleoli. In other cells, the pattern of nuclear
labelling could be very complex. The different nuclear localisation
patterns will be presented separately below. In TpMD409 cells
reactivity with schizonts could clearly be demonstrated (Fig. 4D).
Co-staining with antibodies against the schizont surface protein
PIM indicated that anti-SVSP antibodies predominantly recog-
nized SVSPs located inside the schizont rather than on its surface.
A marked dotted pattern, potentially representing the presence of
SVSP in vesicles was observed. Anti- TP03_0882 antibodies did not
label all parasites. In cultures of T. parva (Muguga)-infected cells,
antibodies recognised schizonts in less than 5% of the cells (see also
Fig. 4D). One possibility is that not all parasite express
TP03_0882. Alternatively, it is possible that in a large number
of parasites the protein is expressed, but only at levels that are
beyond detection by the anti-SVSP antibodies.
These results provide the first evidence for SVSP expression at
the protein level by the Theileria parasite.
The SVSP TP03_0882 targets nucleoli and other
compartments within the nucleus of mammalian cells
In order to test whether SVSPs, which are potentially secreted
into the host cell cytoplasm, have a tropism for specific host cell
structures or compartments, we expressed TP03_0882 lacking the
Figure 2. Quantitative RT-PCR analysis of SVSP expression
patterns in different T. parva-infected cell lines. A. Comparison of
SVSP transcript levels in T and B cell lines transformed with the T. parva
(Marikebuni) A3 clone. Cells originated from the same animal (211).
Relative transcript levels for 11 selected SVSP genes (listed on the right)
were assessed by qRT-PCR in the cell lines 211T-A3 and 211B-A3.
Dashed lines indicate log(2) ratios of 0.9 and -0.9, the arbitrarily defined
Index threshold used for microarray analysis above which differential
expression of genes is considered significant. For one gene no
transcripts were detected (ND). B. SVSP transcript levels in the T. parva
(Marikebuni) A3-infected cell lines 211T-A3 (dark bars) and 211B-A3
(pale bars) compared to a third cell line 951T-F44, infected with a
different T. parva (Marikebuni) clone (F44).
doi:10.1371/journal.pone.0004839.g002
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predicted N-terminal signal peptide in various mammalian cell
lines and monitored localisation by immunofluorescence micros-
copy. Heterologous expression of a full-length TP03_0882-eGFP
fusion protein in U2OS cells revealed that the protein almost
exclusively localised to the nucleus (Fig. 5A). Within the nucleus
different localisation patterns could be observed. In some cells,
TP03_0882-eGFP accumulated mainly in compartments resem-
bling the nucleoli (Fig. 5A, left panels), whereas in other cells the
protein was found predominantly in the nucleoplasm while
nucleoli were clearly excluded (Fig. 5A, right panels). The same
localisation patterns were found upon expression of TP03_0882
containing a C-terminal V5 epitope tag, indicating that the
nuclear accumulation is not an artefact caused by the eGFP
fusion portion of the polypeptide. In addition, similar patterns
were observed when anti-SVSP antibodies were used (not shown).
To confirm the nucleolar localisation counterstaining with
anti-nucleolin was performed. Fig. 5B shows TP03_0882-V5
colocalisation with nuclear structures clearly recognised by
anti-nucleolin antibodies. In a number of cells, TP03_0882-V5,
in addition to targeting nucleoli, was also found to localise to
other nuclear structures (Fig. 5C). While a large proportion of
TP03_0882-V5 could be found in the nucleoli (recognizable as
dark-staining areas by phase contrast microscopy), other, clearly
defined spherical structures of unknown origin were also strongly
labelled. Finally, in other cells, TP03_0882-V5 failed to associate
or associated only weakly with nucleoli and predominantly the
spherical nuclear structures were labelled (Fig 5D). Dual
labelling with anti-V5, visualising SVSP, and antibodies that
recognise telomeres did not reveal any colocalisation (not
shown). Similar localisation patterns were detected in all
transfected cell lines examined, including COS-7, HeLa and T.
annulata-infected macrophages (not shown). When TP03_0882
constructs lacking the N-terminal 368 aa were expressed, nuclear
localisation still occurred, indication that the QP-rich variable
region does not contribute to nuclear translocation (data not
shown).
Figure 3. qRT-PCR analysis of five SVSP genes in seven different cloned T. parva–infected cell lines. The expression of five SVSP genes,
TP03_0869, TP03_0883, TP03_0887, TP04_0018 and TP04_0921 was monitored in seven cell lines transformed by different T. parva clones (see Table 2
for cell lines). For each gene and each cell line, the relative fold difference in relation to the cell line with the lowest transcript level of the respective
gene (indicated as 1.0, labeled with *) is indicated. Data represent the mean of the transcript levels from two independent culture flasks. The actual
fold difference is indicated at the top of the bar. Error bars denote the standard error of the mean. Differently coloured bars indicate cell lines from
different animals. Dotted bars indicate B cell lines, bars with no pattern indicate cd T cells, and CD4+ T cells are indicated with striped bars.
doi:10.1371/journal.pone.0004839.g003
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Figure 4. Detection of recombinant and parasite SVSP by immunoblot and immunofluorescence analysis. A. The C-terminal region of
SVSP TP03_0882 was expressed as a V5/His-epitope tagged protein in bacteria and subjected to immunoblot analysis using antibodies raised in rats
against the same polypeptide (anti-SVSP) or anti-V5 antibodies. Open arrowhead indicates the uncleaved protein; closed arrowhead indicates C-
terminal TP03_0882 after removal of the V5/His epitope tag by AcTEV protease. B. BoMac cells were transfected with untagged and TY-tagged full
length TP03_0882 and analysed by immunoblot, using anti-SVSP or anti-TY antibodies. The position of SVSP and two TY-tagged control proteins
SAG1-mic2 and SAG1-mic20 are indicated. A Ponceau-stained filter is added for loading control and also shows the position of the molecular weight
markers. line 1: BoMac transfected with pmaxGFP (Amaxa); line2: BoMac transfected with pmaxCloning-TP03_0882; line 3: BoMac transfected with
pmax-TP03_0882TY; line 4: BoMac transfected with pcDNA-SAG1-Ty-MIC2; line 5: BoMac transfected with pCAN-SAG1-Ty-MIC20; line 6: Whole cell
lysate of T. parva (Muguga)- infected cells (TpMD409 CD8+ T cell). C. Detection of TP03_0882 SVSP expressed as a TY-tagged protein in BoMac cells.
The nuclei of two cells are stained by DAPI. The cell on the left expresses SVSP as indicated by its reactivity with TY antibodies. The cell is also labelled
after staining with anti-SVSP antibodies, showing nuclear localisation of the expressed protein. Scale bar: 20 mm. D. Cytospin preparations of T. parva
(Muguga)-transformed cells (TpMD409 CD8+ T cells) mixed with uninfected bovine control BL20 cells were fixed in paraformaldehyde and analyzed
by indirect immunofluorescence using anti-SVSP antibodies (green) and anti-PIM antibodies (red). Host and parasite nuclei were stained with DAPI
(blue). The control cell in the middle does not harbour a parasite and is negative for PIM and SVSP. Both the cells at the top and the bottom are
parasitised and thus labelled with anti-PIM. Only the parasite in the cell at the bottom, reacts with antibodies raised against TP03_0882 SVSP (green)
partly revealing a vesicular staining pattern. Merge is an overlay of the three panels. Scale bar: 10 mm
doi:10.1371/journal.pone.0004839.g004
Theileria SVSP Expression
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Functional analysis of potential, parasite-encoded
nuclear localization signals
Importation of proteins into the nucleus is classically mediated
by recognition of nuclear localisation signals (NLS), which fall into
two major classes. Analysis of the TP03_0882 amino acid sequence
using the PsortII [34] and NucPred [35] prediction programs
revealed the presence of two potential NLS. The NucPred
algorithm predicted an SV40 large tumor antigen-type NLS
(designated NLS1, aa 340–351; see Fig. 1). A bipartite NLS (aa
394–410; NLS2) was detected using the PSORTII algorithm. The
presence of NLS is not specific for this individual gene, since using
both algorithms, putative nuclear import motifs could be found in
78% of the T. parva SVSP family members (Table S2).
To investigate to what extent these NLS contribute to targeting
TP03_0882 to the nucleus, constructs lacking either NLS1
(pTP03_0882DNLS1), NLS2 (pTP03_0882DNLS2) or both
(pTP03_0882DNLS1+2) were generated and the sub-cellular
localisation of the V5-epitope tagged proteins monitored by
Figure 5. SVSP TP03_0882 expressed in U2OS cells localises to different nuclear compartments. A. TP03_0882 was expressed as eGFP
fusion protein in U2OS cells. Cells growing on coverslips were fixed with paraformaldehyde. DNA was stained with DAPI (blue). Of the two cells shown
in the panels on the left, one expresses SVSP which is localised to the nucleoli. The panels on the right show a cell with a nucleoplasmic SVSP
localisation pattern. Scale bar: 20 mM. B. Cells transfected with a plasmid encoding V5-tagged SVSP TP03_0882 were fixed with methanol and stained
with antibodies directed against nucleolin (as nucleolar marker, green) or V5 (SVSP-expressing cell, red). The overlay (merge) reveals the colocalisation
of SVSP and nucleolin in the nucleoli. Scale bar: 25 mm. C. In some transfected cells, SVSP (green) localises to nucleoli (white arrows) and other nuclear
structures (orange arrows). In the left panel, nucleoli were visualized by phase contrast (dark areas). In the middle panel, SVSP is visualised using anti-
V5 antibodies. Merge indicates the overlay of both panels. Scale bar: 20 mm. D. In some cells, SVSP (anti-V5, green) does not localise to the nucleoli
(stained with anti-nucleolin, red) and is only found in dense nuclear bodies. Nuclei are stained blue (DAPI). Scale bar: 20 mm.
doi:10.1371/journal.pone.0004839.g005
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immunofluorescence microscopy in transfected U2OS cells. Upon
deletion of NLS1, the protein still translocated to the nucleus, but,
in contrast to wild-type TP03_0882-V5, a large proportion of the
protein was retained in the cytoplasm (Fig. 6). Similar observations
were made when NLS2 was deleted (pTP03_0882DNLS2). Upon
removal of both nuclear localisation motifs (pTP03_
0882DNLS1+2), however, the protein was to a large extent
excluded from the nucleus, indicating that NLS1 and NLS2 can
function independently, but that both motifs are required for
optimal and efficient import of TP03_0882 into the nucleus. For a
minority of other members of the SVSP family such as TP02_0955,
PSORTII or NucPred failed to identify aa sequences predicting an
NLS. When epitope-tagged TP02_0955-V5 was expressed in
U2OS cells, the protein remained almost exclusively in the
cytoplasm, similar to TP03_0882DNLS1+2.
Discussion
This study presents an initial characterisation of the expression
of the T. parva SVSP family, the largest gene family identified in
Theileria so far [24,25]. We found that in three different cell lines
infected with cloned T. parva (Marikebuni) parasites, transcripts
corresponding to more than 65% of SVSP genes are expressed
simultaneously. This is in agreement with the findings of a whole-
transcriptome analysis by MPSS, performed on a T. parva
(Muguga)-infected cell line [28] which showed that SVSP mRNA
can be detected at low to medium levels and also that genes with
similar expression levels are distributed over the eight subtelo-
meres showing no clustering at specific locations.
While SVSP transcript levels in different infected cell lines
appear to be largely comparable, specific SVSP genes exhibiting
differential expression were identified. We investigated the effects
of three variables that could conceivably have an impact on SVSP
expression levels: the individual animal background the infected
lymphocytes were derived from, the host cell type (T or B
lymphocyte) and the parasite genotype. The latter was found to be
the key determinant of differential expression between copies
within the gene family. Cell lines containing clonal parasite
genotypes showed SVSP mRNA expression patterns that differed
between the clones, but were not affected by host cell type or
animal background (Figs. S1 and 2). The most pronounced
differences were found for the SVSP genes TP03_0869 and
TP04_0921, located on the reverse strands of chromosomes 3 and
4. When compared to other SVSPs, the only obvious difference is
that in TP04_0921, the QP-rich region is lacking, which is not the
case for TP03_0869. The absence of the QP-rich region has also
been observed for a few other SVSPs, however, and is unlikely to
explain the differences in mRNA expression. Like most SVSPs,
TP03_0869 and TP04_0921 contain a predicted signal peptide
potentially allowing access to the secretory pathway, two FAINT
domains in the C-terminal region and no predicted transmem-
brane domains, which is consistent with secretion. While
TP03_0869 has no special position in the SVSP array,
TP04_0921 is the most telomere-proximal SVSP gene on the
reverse strand of chromosome 4. Although no absolute quantifi-
cation was carried out, qRT-PCR experiments revealed that,
compared to all other SVSP genes, the Ct values of TP03_0869 and
TP04_0921 are much higher in the cell line 951T_F44, compared
to other cell lines. This suggests that transcription of the two genes
is markedly downregulated in 951T_F44 rather than upregulated
in the other cell lines.
The sequences of TP03_0869, TP03_0883 and TP04_0921
(showing the highest differences in transcript levels between the
different parasite genotypes) and the intergenic region between
Figure 6. Identification of two functional NLS in SVSP
TP03_0882. U2OS cells were transfected with plasmid constructs
encoding V5-tagged forms of TP03_0882 containing both NLS
(TP03_0882), lacking NLS1 (TP03_0882DNLS1), lacking NLS2
(TP03_0882DNLS2) or both NLS (TP03_0882DNLS1+2). In addition, cells
were also transfected with a plasmid encoding TP02_0995, an SVSP
predicted not to contain a NLS. Cells were fixed in methanol and SVSP
localisation monitored using anti-V5 antibodies (green). DNA was
stained with DAPI (blue).
doi:10.1371/journal.pone.0004839.g006
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TP04_0928 an TP04_0921 are conserved between the different
parasite genotypes, indicating that differences in mRNA expres-
sion are not caused by polymorphism. Polymorphism is not
unexpected as it is prevalent in clusters of neighbouring genes of
the SfiI fragment related family which are also subtelomeric [33].
We also established that mRNA expression patterns appear to
be fairly stable as mRNA expression of three SVSP genes tested in
different cell lines remained largely constant over an observation
period of up to 8 weeks. Whether SVSP expression in cloned
parasites would also be constant in vivo, represents an interesting
issue for future investigation.
It will be of interest to determine whether individual parasites
express single SVSP mRNAs, or whether a selection of different
SVSP genes can be expressed by a single schizont. Also, since
schizonts are multinuclear, it remains to be established whether
individual SVSP genes are transcribed in one or several schizont
nuclei within a single infected cell.
Raising antibodies to SVSPs proved very difficult and required
multiple attempts in different animal species. This is in marked
contrast to the schizont surface protein PIM, which also has a
QP-rich domain and –as indicated by its name-is very
immunogenic, both in cattle and mice. The observation that
polyclonal antibodies directed against the SVSP TP03_0882 show
strong staining in only a small number of parasitized cells
indicates that not all parasites express the protein or that
expression levels vary considerable between individual parasites.
It also suggests that antibodies directed against the structurally
conserved SVSP C-terminal domain encoded by TP03_0882
probably do not generally cross-react with other SVSPs. At this
stage we cannot rule out the possibility that SVSP TP03_0882 is
expressed at low levels below the detection threshold of
immunofluorescence analysis in additional cells, or that more
than one SVSP is expressed per parasite. Similar results were
obtained when other cell lines were investigated, suggesting that
restricted and/or strongly varying levels of expression is a typical
feature of SVSPs.
Immunofluorescence analysis showed a clear accumulation of
TP03_0882 SVSP in vesicular structures, supporting the notion
that SVSPs are incorporated into the parasite secretory pathway.
Transfection studies in mammalian cells also confirm that the
predicted NLS could help target SVSPs to the host cell nucleus.
Nevertheless, under the conditions used, the anti-SVSP antibodies
that we generated did not allow us to confirm that SVSPs are
indeed secreted into the host-cell cytoplasm and translocate to the
host cell nucleus. It is possible, that only small amounts of SVSP are
secreted and that our detection tools are not sensitive enough.
Alternatively, it is possible that secreted SVSPs are rapidly
degraded resulting in low steady state levels of protein.
SVSPs are a unique family with no known orthologues in genera
other than Theileria. The function of both the unstructured N-
terminal QP-rich region and the conserved C-terminal region
containing the FAINT domains are unknown. The fact that the
QP-rich region of the protein is lacking in some SVSPs suggests
that this variable region is not indispensable for protein function. It
also indirectly supports the notion that the conserved C-terminal
domain, which also contains the NLS, could be the main
contributor to the–still unknown-biological function(s) of SVSPs.
It is intriguing to note that TP03_0882 localises to defined nuclear
structures when expressed in mammalian cells. Nuclear localisa-
tion has also been observed for other Theileria proteins such as
TashAT and SuAT proteins [15,16,36,37]. Ectopically expressed
TP03_0882 was frequently found to localise to the nucleoli. The
nucleolus is a multifunctional subnuclear compartment that is best
known as the site where ribosome biogenesis takes place. However,
different studies also point towards an involvement of nucleoli in
processes linked to cell cycle control, senescence, DNA
replication and repair, and the regulation of stress responses
(reviewed in [38]). The possibility that Theileria proteins might
target the host cell nucleolus is interesting in view of the fact that
several viral proteins, including the Rex protein of the
transforming human T-lymphotropic virus (HTLV-1) [39] and
a portion of the adeno-associated virus protein Rep [40] can also
be found in nucleoli. TP03_0882 did not localise to nucleoli in all
cells, however, and was sometimes found in association with
other nuclear structures. Each cell cycle, the nucleolus undergoes
extensive reorganisation and the nucleolar proteome is also
subject to dynamic changes dependent on cellular conditions
[41]. Such changes might represent a factor in determining the
pattern of TP03_0882 localisation to the nucleolus. Alternatively,
nucleolar targeting of TP03_0882 might be subject to cell cycle-
dependent changes in post-translational modifications (see [38]
and references therein).
Whether SVSP genes are expressed in a mutually exclusive
manner as has been described for var genes of P. falciparum remains
to be established. Var genes, many of which are also subtelomeric,
encode PfEMP1, a surface protein involved in adherence of
infected erythrocytes to epithelial cells or to other erythrocytes.
Only one PfEMP1 is expressed at the time and expression involves
multiple layers of control involving chromatin modifications,
nuclear positioning, and promoter-intron interactions [2,42,43].
Switching PfEMP1 expression allows intra-erythrocytic Plasmodium
to avoid clearance by the host spleen. Rather than being expressed
on the surface, SVSPs are predicted to be secreted into the host cell
cytoplasm. Proteins secreted by the Theileria schizont can access the
MHC class I–CD8+ T cell surveillance system which plays a
central role in immunity to T. parva. However, despite the
theoretical abundance of potential candidates [21], in individual
animals, this immunity is tightly focused on only a few
immunodominant MHC–peptide epitope combinations (reviewed
by [19,44] leading to a limited cross-protection between different
strains. At this stage, it is not known how efficiently SVSPs are
processed for presentation through the MHC class I pathway.
Nevertheless, assuming each individual SVSP released into the host
cell cytoplasm could potentially provide epitopes capable of
priming protective cytotoxic responses, the simultaneous release
of a large number of similar SVSP proteins would by definition
increase the chances of detection and elimination of parasitised
cells. Our initial findings using antibodies directed against
TP03_0882 suggest that this specific SVSP is expressed by only
a small fraction of the parasites. Although we cannot exclude the
concurrent expression by the same parasite of additional SVSPs,
our initial findings indicate that the expression of individual
SVSPs may be restricted. It has been shown that aminopeptidases
in the endoplasmic reticulum that process antigenic precursors
generated by proteasomal degradation, thus generating peptides
suitable for presentation by MHC class I molecules, fail to trim
prolines that flank the NH2-termini of these precursors [45]. To
what extent prolines in the QP-rich region of SVSPs might
interfere with efficient peptide generation remains to be
established.
In conclusion, using cell lines derived from individual T. parva
clones, we provide a first characterisation of the expression pattern
of members of this large and intriguing T. parva gene family. SVSP
genes are also found in the closely related parasite T. annulata,
potentially reflecting a conserved biological role. The tropism
SVSPs show for different sub-nuclear compartments of the
mammalian cell could provide important clues concerning their
biological function.
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Materials and Methods
Cell lines and parasites
Cloned T. parva-infected cell lines used for analysis of SVSP-
transcript patterns (Table 2) were generated and cultured as
described [29,30,31]. Parasite genotypes A3, F31, F44, F53 are
referred to as 72-01, 72-30, 72-27 and 72-29 respectively in [31]
and originate from stabilate 72. The cell line 951T_I8 was
generated from a different T. parva (Marikebuni) stabilate
originally obtained from Kenya Agricultural Research Institute
(KARI). The T. parva (Muguga) clone 80.9 was newly generated
and is not published. Parasite genotypes were determined with T.
parva-specific satellite markers [31,46] and host cells were typed
using flow cytometry. Native SVSPs were detected in T. parva
(Muguga)-infected CD8+ T cells [47]. Expression of recombinant
SVSP was analyzed in U2OS and BoMac cells cultured under
standard conditions.
Microarray and quantitative real-time PCR analysis
Total RNA was extracted from schizont-infected cells using the
RNeasy Mini Kit according to the manufacturer’s protocol
(QIAGEN). Each infected cell line was represented by two
biological replicates. RNA was treated on-column with RNase-free
DNase (QIAGEN) to remove contaminating genomic DNA.
Conventional end-point PCRs were performed with T. parva actin
(59-CGGGATCCGACCCACAATGTGCCA-39 and 59-
CGGAATTCACGGTGCACAATATT-39) and PIM primers
(59-CGAAGCTTGAAAACATGAAGATCTTTCCC-39 and 59-
TACGCGGCCGCTTAACAACAATCTTCGTTAATGCG-39)
using GoTaq DNA Polymerase (Promega) to detect contamination
with genomic DNA. The RNA was considered ‘DNA-free’ when
no amplification product was detectable after 30 cycles.
For microarray analysis, a direct two-colour experimental
design was used to compare parasite transcripts levels using 70-
mer oligonucleotide microarrays containing 4060 T. parva genes
(Kang’a et al., in preparation). Hybridisations were performed
using 15–20 mg of Cy-dye labelled amplified-RNA (aRNA) from
each infected cell line. Briefly, cDNA targets were first prepared
from 5 mg of total parasite RNA extracted from each T. parva-
infected cell line by reverse transcription followed by in vitro
transcription with simultaneous incorporation of amino-allyl
dUTP using the Aminoallyl Message Amp RNA amplification
kit (Ambion Inc., Austin TX) according to manufacturer’s
instructions. The resulting aRNA was fluorescently labelled using
Cy3 and Cy5 dyes through coupling with amino-allyl dUTP in
0.1M Sodium Carbonate buffer. The labelled targets were used to
hybridise the 70-mer oligonucleotide probes on the glass slides by
incubation for 16 h at 42uC in a hybridisation buffer consisting of
50% formamide, 56 SSC, 0.1% SDS, and 0.6 mg ml21 salmon
sperm DNA. Flip-dye hybridisations were performed by reversing
Cy-dyes for each pair of hybridised parasite aRNA. Following a
16 h incubation, slides were sequentially washed in 26SSC, 0.1%
SDS for 5 min at 42uC, 0.16SSC, 0.1% SDS for 5 min at room
temperature, 0.16SSC for 5 min at room temperature and dried
by centrifugation. Scanning and data extraction was performed
using GenePixH 4000B Axon scanner and Genepix 5.0 software
respectively (Axon Instruments, Union City CA).
Data were analyzed using the marray packages from the
Bioconductor site (www.bioconductor.org; [48]). Following data
normalisation, executed in two steps, first using within-slide loess
normalisation followed by quantile between–slide normalisation,
we employed linear models [49] to rank the differentially
expressed genes in order of evidence (i.e., P value) of differentially
expressed genes. Briefly, the function lmFit in limma accepts a
model matrix, which describes the experimental design and
produces an output object of class MarrayLM, which stores the
fitted model information for each gene. The fitted model object is
further processed by the eBayes function to produce empirical
Bayes test statistics for each gene, including moderated t-statistics,
P-values and log-odds of differential expression. Genes with
P,0.05 and with log2-fold change (M) value of ,20.9 or .0.9
(representing approximately 2 fold change in transcript abun-
dance) were considered as significantly differentially transcribed.
Since each gene on the array was printed in quadruplicate, the
final list of unique genes was generated by calculating the medians
of in-slide replicates for genes that met these criteria. Accession Nr:
GEO14093.
For quantitative real-time (qRT-PCR), first strand cDNA
synthesis was performed from 2 mg total RNA using RNase H
deficient M-MLV reverse transcriptase and 1 mg oligo(dT) primer
in the presence of RNasin Ribonuclease inhibitor as described by
the manufacturer (Promega). Reverse transcriptase was heat-
inactivated for 5 min at 80uC and to verify the generation of
cDNA products, end-point PCR reactions were performed as
described above.
Transcript levels of selected SVSPs were determined by qRT-
PCR using SYBR green dye technology (Applied Biosystems). The
Primer Express Software v.2.0. (Applied Biosystems) was used to
design the primers shown in Table 1. The oligonucleotide
sequences were analyzed for specificity using BLAST searches
(www.ncbi.nlm.nih.gov/BLAST). Since the housekeeping genes
fructose bisphosphate aldolase (FBA, TP01_0101) and actin
(TP02_0903) are highly conserved in a wide range of species,
coding sequences of the T. parva and bovine homologues were
aligned using CLUSTALW at EMBnet-CH and sequences with
low similarity were selected manually. Primer pairs for these genes
were subsequently designed with the Primer3 software [50]. For
the SVSP TP04_0007, no sequences were found which do not at
the same time occur in at least one other SVSP gene. For this gene,
primers were designed such that the forward primer does not
cross-hybridize with the same genes as the reverse primer. All
oligonucleotides were synthesized by Microsynth (Balgach,
Switzerland). Since the SVSP genes contain highly conserved
regions, primer pairs were first tested and only primer pairs were
used for which single melting peaks were obtained.
Table 1. Primer pairs used for quantitative RT-PCR
Locus Name Forward Primer Reverse Primer
TP01_0004 tgagatgtgcggacaaacca gacccacactcttggcagttg
TP02_0953 gttatggaacatgggcttgga tcatgtggtgttggcggtata
TP02_0954 aaggcatcctgtgccacatc gcctgtggtggctgataaaca
TP03_0869 tgtttaaaaatgatggtgaaggaaatt agtcttttccagacatttcaaccaa
TP03_0877 cactcggatcctttaaatatgtattgc cccataccatcagaccatcaact
TP03_0882 ccatcaagtcaaccaaggtatcag ctctattggttgattaggccgataa
TP03_0883 aactgactttacgattccagactatgtc ttccctccaatatcttgtgtgaac
TP03_0887 ttccggattatcacccaggtt gaaatgtgtaaataggcggaacatt
TP03_0890 gggcctcaagaatatcctggat atgttgataaccaggatcgtagacaa
TP04_0007 tggaaaactggtagaaatgataaatg ttccatcttcatggaggtagataat
TP04_0018 ccccagaccaatatacagtccaa tgtagcgaaaaccaccgtatga
TP04_0921 cataataattggatgtataaaatgctctga cctgacttatcaccaggcttatca
doi:10.1371/journal.pone.0004839.t001
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The efficiency of amplification was assessed for each primer pair
by generating standard curves plotted as Ct versus log concentra-
tion. Only primers and primer concentrations yielding a slope
between 23.2 and 23.6 were used.
All qRT-PCR reactions were performed in duplicates in a total
volume of 25 ml containing Power SYBR Green Master Mix
(Applied Biosystems) and 250 or 500 nM of each primer
(depending on reaction efficiency). For quantification of transcript
levels in the different cell lines, 40 ng cDNA were used per
reaction. The assays were carried out with the ABI Prism 7700
Sequence Detector System and associated Sequence Detection
Software v.1.9.1 (Applied Biosystems) following the manufacturer’s
guidelines. For each cDNA sample, a reaction was carried out with
the corresponding amount of input RNA without reverse
transcription and for each reaction a melting temperature profile
was generated to ensure the amplification of a single product. To
detect unspecific amplification of bovine DNA, control reactions
were performed using cDNA of an uninfected bovine cell line
(BL20) as template.
For final quantification of the relative transcript levels, the
comparative Ct method was applied using fructose-bisphosphate
aldolase (TP01_0101) as an endogenous control and the sample
with the lowest expression level of the respective gene as calibrator.
Generation of anti-SVSP antibodies
The C-terminal part of TP03_0882 (bp 1075–1821, AA 359–
607) was amplified with primers 59-CACCCATGAAACTACT-
CAAAAATC-39 (sense) and 59-TTATCTATATTTGGCTTT-
TATTAAATT-39 (antisense) using pTP03_0882 as template. The
PCR fragment was directly cloned into pET151/D-TOPO
(Invitrogen) a bacterial expression vector resulting in pET151-
TP03_0882C. TP03_0882C protein was over-expressed in E. coli
BL21 star cells (Invitrogen) and the 6xHis tagged protein was
purified over Protino Ni 150 columns (Machery Nagel, #745
100.10). The purified protein was mixed with GERBU adjuvant
(GERBU Biotechnik GmbH, Gaiberg, Germany) and rats were
immunised. The diluted immune serum was used for immunoflu-
orescence and Western blot analysis. These polyclonal antibodies
are not necessarily mono-specific for TP03_0882 and may
recognise more than one SVSP protein, as the protein family has
conserved C-terminal ends and certain epitopes may therefore be
shared with other SVSPs. In order to cleave the V5/His–tag from
recombinant TP03_0882C-V5 40 mg of purified protein was
incubated for 3 h at 30uC in the presence of 20 U of AcTEV
protease, 1 mM DTT and 16TEV buffer (Invitrogen).
Recombinant SVSP constructs
Different versions of TP03_0882 and TP02_0995 were
expressed as recombinant proteins in mammalian cells either
tagged with V5 or TY epitopes or as eGFP fusion proteins. All
constructs expressed in mammalian cells lack the predicted signal
peptide for secretion. To generate pTP03_0882, PCR was
performed with the primers 59-ATAAGCTTATGCCTGAT-
CAACCTGCTGATGAT-39 (sense) and 59-GCCTCGAGTCTA-
TATTTGGCTTTTATTAAATT-39 (antisense) using genomic
DNA from the T-cell line 803 containing T. parva (Muguga) as
template. Since in preliminary experiments we had initially
isolated an incomplete cDNA clone corresponding to
TP03_0884, the DNA sequence of the primers was based on the
TP03_0884 gene locus, also a member of the SVSP gene family. As
all SVSP family members have very conserved 59- and 39-ends in
our PCR reaction TP03_0882 was amplified instead, resulting in a
protein with the following changes compared to the original
TP03_0882 protein sequence published in the TIGR T. parva
genome database: S30A, E31D, T607R, all conservative amino
acid changes, introduced by using the above described primers.
We found two additional changes in our PCR fragment by
comparing the DNA sequence to the TP03_0882 sequence in the
TIGR database. Both changes are A to G transitions which lead to
the following amino acid changes: D45G and T158A. The PCR
product was directly cloned into pCRH2.1-TOPO (Invitrogen)
resulting in pTOPO-TP03_0882 and from there sub-cloned into
the mammalian expression vector pcDNA3.1/V5-HisA (Invitro-
gen) using the restriction enzymes EcoRI and HindIII. The final
construct produces a truncated version of TP03_0882 from amino
acid 26 to 607 containing the above-indicated changes and is
referred as TP03_0882 in this paper. pTP03_0882 was used as
template for constructing three plasmids coding for TP03_0882
versions lacking either one of the two putative NLS or both. To
construct pTP03_0882DNLS1 the following primers were used to
amplify the N-terminal part (bp 26–1098) of TP03_0882: 59-
TAATACGACTCACTATAGG-39 (sense), 59-CTGTCCATG-
GAGTTGATTTTTGAGTAGTTTC-39 (antisense) and the two
following primers were used to amplify the C-terminal part (bp
1144–1821): 59-GCTGCCATGGGATCAAACTGAGAAGAAA-
GATG (sense) and 59-GCCTCGAGTCTATATTTGGCTTT-
TATTAAATT (antisense). The amplicon encoding the N-
terminal section was digested with the restriction enzymes EcoRI
and NcoI, the fragment corresponding to the C-terminal was
digested with NcoI and XhoI. Both fragments were ligated
simultaneously into pcDNA3.1/V5-His linearized with EcoRI
and XhoI. The same cloning strategy was used to construct
Table 2. T. parva-infected cell lines established by transformation with different T. parva clones.
Cell line Parasite isolate Parasite genotype Animal Host cell type Reference
211T_A3 (211-72-29) Marikebuni A3 211 CD4+ [30]
211B_A3 (211-72-33) Marikebuni A3 211 B cell [30]
951T_F44 (951-F44) Marikebuni F44 211 CD4+ [31]
951B_A3 (951-A3) Marikebuni A3 951 B cell [31]
951T_I8 (951-I8) Marikebuni I8 951 cd
951T_F31 (951-F31) Marikebuni F31 951 cd [31]
951T_F53 (951-F53) Marikebuni F53 951 CD4+ [31]
951T_S80.9 (951-S80.9) Muguga 80-9 951 CD4+ none
TpMD409 Muguga D(409) CD8+ [47]
doi:10.1371/journal.pone.0004839.t002
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pTP03_0882DNLS1+2. The same N-terminal part (bp 26–1098)
as used for construction of pTP03_0882DNLS1 cut with EcoRI
and NcoI was ligated with the C-terminal part (bp 1231–1821)
amplified with the primers 59-GCATGCCATGGAATTATCTGG-
GAAAGCTTG-39 (sense) and 59-GCCTCGAGTCTATATTT-
GGCTTTTATTAAATT-39 (antisense) and cut with NcoI and
XhoI into EcoRI/XhoI linearized pcDNA3.1/V5-His. The first
TP03_0882DNLS2 construct was made as eGFP fusion protein in
the vector peGFP-N3 (BD Biosciences Clontech). Amplification of
the N-terminal part (bp 26–1179) was performed with the primers
59-TAATACGACTCACTATAGG-39 (sense) and 59-GCATGC-
CATGGAACAGATTCTTCACCATC-39 (antisense). The C-ter-
minal part (bp 1231–1821) was amplified with the primers 59-
GCATGCCATGGAATTATCTGGGAAAGCTTG-39 (sense) and
59-CGCGGATCCGGTATATTTGGCTTTTATTAAATTT-39
(antisense). The PCR product of the N-terminal part was cut with
EcoRI and NcoI, the PCR product of the C-terminal part was cut
withNcoI and BamHI, both fragments were ligated simultaneously to
EcoRI/BamHI linearised peGFP-N3 to generate pTP03_
0882DNLS2-EGFP. This vector was used to generate
pTP03_0882DNLS2. pTP03_0882DNLS2-EGFP was cut with
HindIII to cut out a 1176 bp fragment harbouring the DNLS2
truncation. This DNLS2 HindIII fragment was ligated into HindIII
cut pTP03_0882 replacing the N-terminal part containing NLS2.
The resulting vector is called pTP03_0882DNLS2. For expression
of the TP03_0882 as a GFP fusion protein, the cDNA was
subcloned from pTOPO-TP03_0882 using the restriction enzymes
SacI and ApaI and ligated into pEGFP-N3 cut with the same
enzymes. The resulting vector is called pTP03_0882-eGFP. We also
cloned a gene of the SVSP family, which does not originally contain
a NLS, TP02_0955 a single exon gene. The gene lacking the N-
terminal region coding for the signal peptide for secretion (bp 58–
1683) was amplified using the primers 59-AATGAATTCACCAC-
CATGGATAGATATCCCTATCAC-39 (sense) and 59-TGAC-
CTCGAGATAATCTTTTACATTCTTTCTA-39 using genomic
DNA of the T-cell line 951-F31 harbouring T. parva (Marikebuni) as
template. The PCR product was digested with the restriction
enzymes EcoRI and XhoI and ligated into EcoRI/XhoI linearized
pcDNA3.1/V5-His for expression in mammalian cells resulting in
pTP02_0955. All DNA fragments amplified by PCR were
sequenced (Microsynth AG, Balgach, Switzerland) to verify the
correct DNA sequence. To bypass problems of low expression levels
with the pcDNA constructs, most of the SVSP constructs were
subcloned into the pmaxCloning expression vector (Amaxa) using
standard protocols, resulting in much higher SVSP expression levels
in mammalian cells.
Immunofluorescence analysis
For detection of endogenous SVS proteins, cytospins with T.
parva-infected T-cells (TpM D409) were performed. All the
following steps were carried out at room temperature. Cells were
fixed in 4% paraformaldehyde for 20 min and subsequently
permeabilized in 0.2% Triton X-100 (prepared in PBS) for 5 min.
Nonspecific binding was blocked with PBS containing 10% heat
inactivated FCS (FCS/PBS) for 10 min. Anti-SVSP immune serum
was diluted 1:200 in FCS/PBS and applied for 1 h. Cells were
washed three times with PBS and incubated with secondary
antibody Alexa488-conjugated goat anti-rat antibody (1:1000;
Invitrogen, Molecular Probes A-11006) for 1 h. Cells were washed
five times with PBS and then incubated with anti-PIM 40.2
antibodies (1:1000; IL-S40.2, International Livestock Research
Institute, Nairobi, Kenia) in FCS/PBS for 1 h to visualize the
parasite surface. Cells were washed again three times with PBS
and incubated with secondary antibody Texas Red-conjugated
goat anti-mouse antibody (1:800; Invitrogen, Molecular Probes
T862) for 1 h in FCS/PBS. DNA was stained for 1 min with
DAPI (49,6-diamidino-2-phenylindole, dihydrochloride; Molecular
Probes, D-21490) at a concentration of 1 mg ml21 in PBS. Finally,
the slides were covered with a coverslip using anti-fading mounting
reagent (Vectashield). For the overexpression studies, U2OS cells
were grown on glass coverslips and plasmid DNA was transfected
with lipofectamine (Invitrogen life technologies) according to the
manufacturer’s protocol and cells were analyzed 24 h post
transfection. For immunofluorescence the same protocol was
applied as for detection of endogenous SVSPs but cells were mainly
fixed in cold (220uC) methanol for 10 min and primary antibodies
raised in mouse or rabbit could be applied together as well as
secondary anti-mouse and anti-rabbit antibodies. Primary anti-
bodies were diluted as followed: mouse anti-V5 antibody (1:500;
Invitrogen life technologies R960-25), to visualize nucleoli rabbit
anti-C23 (H259) antibodies were used (1:200; Santa Cruz sc-
13057). Secondary antibodies were used at the following dilutions:
Alexa488-conjugated goat anti-rabbit antibody (1:1500; Molecular
Probes A-11034), Alexa488 conjugated goat anti-mouse antibody
(1:1500; Molecular Probes A-11029), Texas Red-conjugated goat
anti-mouse antibody (1:800; Invitrogen, Molecular Probes T862).
To visualize eGFP fusion proteins cells were fixed in 4%
paraformaldehyde for 10 min at room temperature. DNA was
stained with Dapi and coverslips were mounted onto slides using
mounting reagent (Vectashield). All samples were analyzed using a
Nikon Eclipse fluorescence microscope 80i and digital images were
generated and processed using the Openlab 3.1.5 software.
Immunoblot analysis
Whole cell lysates of T. parva-infected TpM(409) CD8+T-cells
or transfected BoMac cells were prepared in 16 La¨mmli-buffer
containing 4% b-mercaptoethanol. The lysates were sonicated and
insoluble cell debris was removed by centrifugation at 23’0006g
for 10 min at 4uC. Samples were stored at 220uC and aliquots of
20 ml cell lysate (26105 cells) were used for Western blot analysis.
Immunoblot analysis was performed according to standard
procedures. Samples were boiled for 5 min before loading onto
a 10% SDS-polyacrylamide gel. After blotting, the nitrocellulose
membranes were blocked for 1 h with 5% milk-TBST (10 mM
Tris, pH 8.0; 150 mM NaCl; 0.05% Tween-20). The membranes
were incubated in the same blocking buffer containing rat anti-
SVSP immune serum diluted 1:500, mouse anti-TY antibodies
1:2000 (D. Soldati, Geneva, Switzerland) or mouse anti-V5
antibodies (P/N 46-0705, Invitrogen) 1:2000 over night at 4uC.
Membranes were washed 36 for 5 min in TBST and then
incubated for 1 h at room temperature in 5% milk-TBST
containing secondary antibodies: horseradish peroxidase-conju-
gated goat anti-rat antibody (SC-2006, Santa Cruz Biotechnolo-
gy,) or horseradish peroxidase-conjugated rabbit anti-mouse
antibody (P0260, Dako) both diluted 1:2000. Membranes were
washed 36 for 5 min with TBST and once for 5 min with TBS
(10 mM Tris, pH 8.0, 150 mM NaCl). For visualisation of the
signal in the FUJIFILM LAS-3000 system, the ECL detection
system was used according the manufacturer’s instructions
(Amersham Biosciences).
Supporting Information
Figure S1 Schematic presentation (adapted from (Bishop et al.,
2005)) depicting the organisation of SVSP genes at the subtelo-
meres of the four T. parva chromosomes. SVSP genes are shown in
red and the numbers represent the original numbering allocated to
each of the proteins encoded by the T. parva (Muguga) SVSP genes
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(Gardner et al., 2005). Sfi subtelomeric related family genes are
marked in blue. Genes unrelated to these two families are coloured
green and telomeres are grey. Asterisks indicate SVSP transcript
levels as defined by Bishop et al. (Bishop et al., 2005) by MPSS
analysis of a cell line established by infection with a T. parva
(Muguga) clone. One asterisk reflects 4 to 99 transcripts per
million; two asterisks indicates 100 to 999 transcripts per million;
the absence of an asterisk indicates that no transcripts were
detected. Microarray (MA, circles) or quantitative real-time PCR
(qRT, squares) analyses were also carried out to investigate mRNA
expression in cell lines established by infection with different T.
parva (Marikebuni) clones (see results section). Pairs of genes
numbered 1-5 are identical. The absence of circles or squares
means that these genes were not analysed. Open circles or squares
indicate genes for which no transcripts were detected. Red circles
and squares reflect genes for which no difference in mRNA
expression was found. Red circles with a white centre indicate that
one or both identical genes are expressed. Genes found to be
differentially expressed using MA or qRT are marked by green
circles or squares, respectively.
Found at: doi:10.1371/journal.pone.0004839.s001 (0.57 MB EPS)
Table S1 Microarray analysis of SVSP expression patterns in
three cell lines
Found at: doi:10.1371/journal.pone.0004839.s002 (0.13 MB
DOC)
Table S2 List of T. parva SVSP genes, indicating the presence or
absence of a signal peptide and/or nuclear localisation signal
Found at: doi:10.1371/journal.pone.0004839.s003 (0.09 MB
DOC)
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